Vercise™ DBS Dystonia Prospective Study
RecruitingNCT02686125Phase: Not specifiedStarted 2016-03-07
Summary
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
Eligibility
Sex
ALL
Min Age
7 Years
Max Age
None
Locations
AZ Sint-LucasGhent, Belgium
UZ GasthuisbergLeuven, Belgium
Queen Elizabeth II Health Sciences CenterHalifax, Canada
University Berlin, Charite Virchow Standort, WeddingBerlin, Germany
Uniklinik KölnCologne, Germany
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT02686125